Related Experiment Video
Updated: May 3, 2026
08:51
Evaluation of Polymeric Gene Delivery Nanoparticles by Nanoparticle Tracking Analysis and High-throughput Flow Cytometry
Published on: March 1, 2013
15.6K
Pullulan-protamine as efficient haemocompatible gene delivery vector: synthesis and in vitro characterization.
S S Priya1, M R Rekha1, Chandra P Sharma1
1Biosurface Technology Division, Biomedical Technology Wing, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, Kerala, India.
Carbohydrate Polymers
|February 11, 2014
Summary
Researchers developed a novel biodegradable non-viral vector, pullulan protamine conjugate (PPA), for effective gene delivery. This PPA system demonstrates excellent cellular uptake and high gene expression, showing promise for non-toxic gene therapy applications.
Area of Science:
- Biomaterials Science
- Gene Therapy
- Nanotechnology
Background:
- Effective non-viral vectors are crucial for safe and efficient gene delivery.
- Current vectors often face challenges with toxicity and transfection efficiency.
- Biodegradable materials offer potential for improved gene delivery systems.
Purpose of the Study:
- To design and characterize a novel biodegradable non-viral vector by conjugating protamine to pullulan.
- To evaluate the potential of the pullulan protamine conjugate (PPA) as a non-toxic and haemocompatible gene delivery system.
- To assess PPA's efficiency in cellular uptake and gene expression.
Main Methods:
- Synthesis and characterization of pullulan protamine conjugate (PPA) using NMR, FTIR, and DSC.
- Physicochemical analysis including particle size, surface charge, and buffering capacity.
- Evaluation of DNA protection, plasma stability, cellular uptake mechanisms, and transfection efficiency in C6 cells.
Main Results:
- PPA nanoparticles were successfully synthesized and characterized.
- The conjugate exhibited favorable buffering behavior and protected DNA from nuclease degradation.
- Studies confirmed efficient plasmid DNA delivery into the nucleus and high gene expression in C6 cells.
- PPA demonstrated good haemocompatibility and non-toxic properties.
Conclusions:
- Pullulan protamine conjugate (PPA) is a promising, effective, non-toxic, and haemocompatible non-viral vector for gene delivery.
- PPA facilitates efficient cellular uptake and high gene expression, indicating its therapeutic potential.
- Further research into PPA could advance the field of non-viral gene therapy.
